Drug Type Small molecule drug |
Synonyms LUF 5826, LUF5826 |
Target |
Action antagonists |
Mechanism A1R antagonists(Adenosine A1 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC16H12F2N4O2S |
InChIKeyFBSFJYUGTIAIKV-UHFFFAOYSA-N |
CAS Registry791619-95-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Nervous System Diseases | Preclinical | United States | 24 Mar 2005 |